Treatment of duodenal and gastric ulcer; Treatment of reflux oesophagitis; Prophylaxis of reflux oesophagitis; Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy treatment for H. pylori-associated ulcers; Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment; Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy; Symptomatic gastroesophageal reflux disease; Zollinger-Ellison syndrome.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
